BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol. 2010;24:647-654. [PMID: 20955967 DOI: 10.1016/j.bpg.2010.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Cheung AC, Juran BD, Schlicht EM, McCauley BM, Atkinson EJ, Moore R, Heimbach JK, Watt KD, Wu TT, LaRusso NF, Gores GJ, Sun Z, Lazaridis KN. DNA methylation profile of liver tissue in end-stage cholestatic liver disease. Epigenomics 2022. [PMID: 35473391 DOI: 10.2217/epi-2021-0343] [Reference Citation Analysis]
2 Sayar S, Gokcen P, Aykut H, Adali G, Doganay HL, Ozdil K. Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis? Sisli Etfal Hastan Tip Bul 2021;55:412-8. [PMID: 34712085 DOI: 10.14744/SEMB.2021.95825] [Reference Citation Analysis]
3 Aygün İ, Kaya M, Alhajj R. Identifying side effects of commonly used drugs in the treatment of Covid 19. Sci Rep 2020;10:21508. [PMID: 33299085 DOI: 10.1038/s41598-020-78697-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Örnolfsson KT, Lund SH, Olafsson S, Bergmann OM, Björnsson ES. Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study. Scand J Gastroenterol 2019;54:609-16. [PMID: 31074667 DOI: 10.1080/00365521.2019.1606931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Han D, Liu J, Jin E, He W. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Jpn J Radiol 2019;37:412-9. [PMID: 30798469 DOI: 10.1007/s11604-019-00822-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
6 Gonzalez RS, Washington K. Primary Biliary Cholangitis and Autoimmune Hepatitis. Surg Pathol Clin 2018;11:329-49. [PMID: 29751878 DOI: 10.1016/j.path.2018.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Cheung AC, Gulamhusein AF, Juran BD, Schlicht EM, McCauley BM, de Andrade M, Atkinson EJ, Lazaridis KN. External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid. Hepatol Commun 2018;2:676-82. [PMID: 29881819 DOI: 10.1002/hep4.1186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Murillo Perez CF, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, Carbone M, Mason A, Corpechot C, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Thorburn D, Hirschfield G, LaRusso NF, Lindor KD, Zachou K, Poupon R, Trivedi PJ, Verhelst X, Janssen HLA, Hansen BE; GLOBAL PBC Study Group. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. Hepatology 2018;67:1920-30. [PMID: 29220537 DOI: 10.1002/hep.29717] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]
9 Cheung AC, LaRusso NF, Gores GJ, Lazaridis KN. Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Semin Liver Dis 2017;37:159-74. [PMID: 28564724 DOI: 10.1055/s-0037-1603324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
10 Sullivan GM. The Burnout Conundrum: Nature Versus Nurture? J Grad Med Educ 2016;8:650-2. [PMID: 28018526 DOI: 10.4300/JGME-D-16-00605.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Floreani A, Spinazzè A, Caballeria L, Reig A, Cazzagon N, Franceschet I, Buja A, Furlan P, Harada K, Leung PS, Gershwin ME, Pares A. Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol 2015;48:254-62. [PMID: 25205363 DOI: 10.1007/s12016-014-8446-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
12 Floreani A, Franceschet I, Cazzagon N, Spinazzè A, Buja A, Furlan P, Baldo V, Gershwin ME. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:192-197. [PMID: 24809534 DOI: 10.1007/s12016-014-8427-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 14.7] [Reference Citation Analysis]
13 Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L. Autoimmune liver disease and concomitant extrahepatic autoimmune disease: . European Journal of Gastroenterology & Hepatology 2015;27:1175-9. [DOI: 10.1097/meg.0000000000000424] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
14 Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015; 7(7): 926-941 [PMID: 25954476 DOI: 10.4254/wjh.v7.i7.926] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 8.4] [Reference Citation Analysis]
15 Han D, He W. Associations Between Magnetic Resonance Imaging Findings and Scores of Liver Function and Histology in Patients with Primary Biliary Cirrhosis. Appl Magn Reson 2015;46:731-9. [DOI: 10.1007/s00723-015-0675-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Meng Y, Liang Y, Liu M. The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis. PLoS One. 2015;10:e0120110. [PMID: 25781184 DOI: 10.1371/journal.pone.0120110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
17 Costello JR, Kalb B, Chundru S, Arif H, Petkovska I, Martin DR. MR Imaging of Benign and Malignant Biliary Conditions. Magnetic Resonance Imaging Clinics of North America 2014;22:467-88. [DOI: 10.1016/j.mric.2014.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
18 Hagymási K, Tulassay Z. [Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties]. Orv Hetil. 2013;154:923-929. [PMID: 23752047 DOI: 10.1556/OH.2013.29640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Ducarme G, Bernuau J, Luton D. [Primary biliary cirrhosis and pregnancy]. J Gynecol Obstet Biol Reprod (Paris). 2014;43:335-341. [PMID: 23628147 DOI: 10.1016/j.jgyn.2013.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
20 Chow IT, James EA, Gates TJ, Tan V, Moustakas AK, Papadopoulos GK, Kwok WW. Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08: 01 and DRB1*11: 01 Is predicted by their structural motifs and correlates with disease risk. J Immunol. 2013;190:4516-4524. [PMID: 23543758 DOI: 10.4049/jimmunol.1202445] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
21 Iannitti T, Rosini S, Lodi D, Frediani B, Rottigni V, Palmieri B. Bisphosphonates: focus on inflammation and bone loss. Am J Ther 2012;19:228-46. [PMID: 22549638 DOI: 10.1097/MJT.0b013e318247148f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
22 Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181-1188. [PMID: 22245904 DOI: 10.1016/j.jhep.2011.10.025] [Cited by in Crossref: 342] [Cited by in F6Publishing: 332] [Article Influence: 34.2] [Reference Citation Analysis]
23 Kovač JD, Daković M, Stanisavljević D, Alempijević T, Ješić R, Seferović P, Maksimović R. Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol 2012;81:2500-6. [PMID: 22100369 DOI: 10.1016/j.ejrad.2011.10.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
24 Polido-Pereira J, Rodrigues AM, Canhão H, Saraiva F, da Silva JA, Fonseca JE. Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review. Clin Rheumatol 2012;31:385-9. [PMID: 22042492 DOI: 10.1007/s10067-011-1879-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kovač JD, Ješić R, Stanisavljević D, Kovač B, Banko B, Seferović P, Maksimović R. Integrative role of MRI in the evaluation of primary biliary cirrhosis. Eur Radiol 2012;22:688-94. [DOI: 10.1007/s00330-011-2296-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]